Boston Heart Diagnostics
Kathleen McGuire has been a key member of Boston Heart Diagnostics since May 2012, progressing to the role of Vice President of Operations. Prior to this position, Kathleen served as Manager, with responsibilities that included overseeing Pre-Analytics, Automated Chemistry, and the HDL MAP. Their extensive experience within the organization highlights a strong background in operations and management in the diagnostics field.
Boston Heart Diagnostics
Boston Heart Lab is a healthcare company that provides cardiovascular disease (CVD) management. Through there combination of proprietary lipid testing capability, sophisticated tools, advanced therapy guidelines, and patient support services, they are providing physicians, patients, and pharmaceutical companies with viable disease management.Unlike other lipid testing companies that are focused on the primary screening market for CVD, their proprietary testing technology allows for the ongoing monitoring of a patient's disease and precise determination of the most appropriate pharmaceutical alternatives. They can provide unique, personalized treatment options to patients with dyslipidemia to determine the efficacy of lipid adjusting drugs in most cases within the first 6 weeks of treatment. Competing methods usually need 6 months.